FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071151 [Registered on: 23/07/2024] Trial Registered Prospectively
Last Modified On: 22/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [preoperative topical steroids on conjunctival histopathology in glaucoma surgery]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of topical steroids on conjunctiva in glaucoma surgery 
Scientific Title of Study   Evaluation of effect of preoperative topical steroids on conjunctival histopathology in glaucoma surgery 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mehak Gupta 
Designation  Post Graduate Resident 
Affiliation  Maulana Azad Medical College 
Address  Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja Ranjeet Singh Marg, LNJP Colony

New Delhi
DELHI
110002
India 
Phone  07982518886  
Fax    
Email  mehakg241@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mehak Gupta 
Designation  Post Graduate Resident 
Affiliation  Maulana Azad Medical College 
Address  Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja Ranjeet Singh Marg, LNJP Colony

New Delhi
DELHI
110002
India 
Phone  07982518886  
Fax    
Email  mehakg241@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mehak Gupta 
Designation  Post Graduate Resident 
Affiliation  Maulana Azad Medical College 
Address  Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja Ranjeet Singh Marg, LNJP Colony

New Delhi
DELHI
110002
India 
Phone  07982518886  
Fax    
Email  mehakg241@gmail.com  
 
Source of Monetary or Material Support  
Guru Nanak Eye Centre, Maharaja Ranjeet Singh Marg, LNJP Colony, New Delhi, Delhi, 110002, INDIA 
 
Primary Sponsor  
Name  Maulana Azad Medical College 
Address  Maulana Azad Medical College, Bahadur Shah Zafar Marg, near Delhi Gate, New Delhi 110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kirti Singh  Guru Nanak Eye Centre  Department of Ophthalmology, Guru Nanak Eye Centre, Maharaja Ranjeet Singh Marg, LNJP Colony, New Delhi, 110002
New Delhi
DELHI 
9968604334

gnecdir@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, MAULANA AZAD MEDICAL COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H401||Open-angle glaucoma, (2) ICD-10 Condition: H402||Primary angle-closure glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Loteprednol etabonate  Low dose topical steroid will be given for 2 weeks along with topical anti-glaucoma medications prior to glaucoma surgery. 
Comparator Agent  NIL  Patients on topical anti glaucoma medications scheduled for glaucoma surgery 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Adult primary glaucoma cases requiring trabeculectomy
Patient on 3 or more different classes of topical antiglaucoma medications for a minimum of 3 months duration
 
 
ExclusionCriteria 
Details  Prior incisional surgery involving conjunctiva
Dry eyes requiring more than or equal to two lubricant drops per day, prior herpetic keratitis
Concurrent non-ophthalmic steroid use
Known steroid responder

 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Conjunctival cellular profile (mean no. of macrophages and other cells)  1 week, 1 month, 4 months  
 
Secondary Outcome  
Outcome  TimePoints 
Bleb morphology by slit lamp examination (IBAGS)  1 week, 1 month, 4 months  
Bleb function by IOP control  1 week, 1 month, 4 months  
ASOCT (Anterior Segment Optical Coherence Tomography) for bleb morphology   1 week, 1 month, 4 months  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a randomised controlled trial to determine effect of preoperative topical low dose steroids on conjunctival histopathology markers for macrophages and other cells. The secondary outcomes measure  the effect of preoperative topical low dose steroids on outcome of glaucoma surgery with respect to bleb morphology (clinical and ASOCT) and IOP at 4 months.

 
Close